Bio-Thera Solutions Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 12, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	9,814	8,025	17,077	9,019	10,696	13,168
Market Cap Growth	26.06%	-53.01%	89.35%	-15.68%	-18.77%	-
Enterprise Value	10,196	8,276	16,905	8,061	9,624	11,899
Last Close Price	23.70	19.38	41.24	21.78	25.83	31.80
PE Ratio	-	-	-	-	130.54	-
PS Ratio	11.61	10.80	24.23	19.82	12.79	72.01
PB Ratio	20.27	11.33	14.08	5.61	5.12	6.57
P/TBV Ratio	37.09	16.58	17.38	6.57	5.79	7.48
P/FCF Ratio	-	-	-	-	67.53	-
P/OCF Ratio	-	-	-	-	45.27	-
EV/Sales Ratio	12.06	11.14	23.99	17.71	11.50	65.07
EV/EBITDA Ratio	-	-	-	-	88.40	-
EV/EBIT Ratio	-	-	-	-	248.38	-
EV/FCF Ratio	-80.83	-	-	-	60.77	-
Debt / Equity Ratio	1.34	0.89	0.40	0.01	0.02	0
Debt / EBITDA Ratio	-	-	-	-	0.29	-
Debt / FCF Ratio	-	-	-	-	0.21	-
Asset Turnover	0.37	0.33	0.32	0.19	0.33	0.11
Inventory Turnover	0.75	0.95	0.99	1.52	0.53	0.45
Quick Ratio	0.32	0.45	0.89	1.65	2.96	3.37
Current Ratio	0.69	0.81	1.39	2.16	3.37	3.81
Return on Equity (ROE)	-55.40%	-53.13%	-27.98%	-26.00%	4.00%	-38.94%
Return on Assets (ROA)	-12.39%	-15.00%	-13.01%	-13.79%	0.97%	-20.72%
Return on Invested Capital (ROIC)	-51.26%	-49.98%	-46.00%	-71.01%	4.86%	-77.41%
Return on Capital Employed (ROCE)	-48.80%	-48.60%	-29.80%	-32.20%	1.90%	-28.10%
Earnings Yield	-3.76%	-6.36%	-2.31%	-5.33%	0.77%	-3.90%
FCF Yield	-1.29%	-2.27%	-4.23%	-7.45%	1.48%	-4.64%
Payout Ratio	-	-	-	-	0.68%	-
Buyback Yield / Dilution	0.15%	0.10%	-0.28%	-1.09%	-1.38%	-16.97%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.